A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive ...

Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), ...

In a recent study conducted by a team from The Ohio State University, US, it was revealed that a staggering 25% of adults, or ...

Vanda Pharmaceuticals’ shares were down more than 10% at $4.45 pre-market today, as the company provided an unfavorable ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

Following a needed reinvention that resulted from the pandemic, there is now a seismic shift taking place in the fitness ...

Discover promising biotech candidates and groundbreaking research offering new hope for treating mitochondrial diseases.

The research subjects were the rodent equivalent of casual drinkers - the type who enjoy a glass of wine with dinner or ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its tradipitant development program.

Viking Therapeutics, Inc. (NASDAQ: VKTX) director J. Matthew Singleton executed a sale of company stock valued at more than $715,000, according to a recent SEC filing. The transactions, which took ...